Related Experiment Videos
Epidemiology and NSAID induced gastropathy
1Department of Internal Medicine and Dermatology, School of Medicine, Hanover, FRG.
The Journal of Rheumatology. Supplement
|March 1, 1991
Summary
Non-steroidal anti-inflammatory drug (NSAID) use increases the risk of gastrointestinal (GI) events and ulcers, particularly in older adults. Further research is needed to identify risk factors for optimal patient management.
Area of Science:
- Gastroenterology
- Epidemiology
- Pharmacology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- NSAID use is associated with significant gastrointestinal (GI) risks, including gastropathy and ulcer complications.
- Existing data highlight increased risk in older populations and with concurrent use of alcohol, anticoagulants, or pre-existing GI conditions.
Purpose of the Study:
- To summarize the epidemiologic evidence on NSAID-induced gastropathy.
- To highlight the prevalence and asymptomatic nature of NSAID-related mucosal damage.
- To underscore the contribution of NSAID gastropathy to serious GI complications and mortality.
Main Methods:
- Review of population-based and clinical epidemiologic studies on NSAID gastropathy.
- Analysis of risk factors associated with adverse GI events in NSAID users.
- Synthesis of evidence regarding NSAID-induced gastropathy and its clinical impact.
Main Results:
- NSAID users face elevated risks of GI events and ulcer complications.
- Older individuals are at higher risk for NSAID-induced gastropathy.
- A substantial proportion of NSAID users experience asymptomatic mucosal damage.
Conclusions:
- NSAID-induced gastropathy is a major cause of severe GI complications and mortality.
- Multivariate risk profiles are needed for optimal management of patients on chronic NSAID therapy.
- Further research is required to refine risk assessment and patient care strategies.